ProPhase Labs, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Earnings (Loss) Per Share (Tables)

Earnings (Loss) Per Share (Tables)

9 Months Ended

Sep. 30, 2016

Schedule of Reconciliation of Applicable Numerators and Denominators of Income Statement Periods

A reconciliation of the applicable numerators and denominators of the income statement periods presented, as reflected in the results of continuing operations, is as follows (in thousands, except per share amounts):

	Three Months Ended						Three Months Ended						Nine Months Ended								Nine Months Ended
	September 30, 2016						September 30, 2015						September 30, 2016								September 30, 2015
	Income		Shares		EPS		Income		Shares		EPS		Loss			Shares		EPS			Loss			Shares		EPS
Basic income (loss) per share	$	167		17,081	$	0.01	$	602		16,597	$	0.04	$	(2,296	)		17,081	$	(0.13	)	$	(2,344	)		16,171	$	(0.14	)

Dilutives:
Options		-		519		-		-		375		-		-			-		-			-			-		-

Diluted income (loss) per share	$	167		17,600	$	0.01	$	602		16,972	$	0.04	$	(2,296	)		17,081	$	(0.13	)	$	(2,344	)		16,171	$	(0.14	)